Tumgik
#PRRT Treatment India
Link
Our Nuclear Oncology Experts have expertise in Alpha PSMA Therapy, I-131 MIBG Therapy, PRRT Therapy, I-131 For Thyroid Cancer, Actinium and Lutetium Therapy in India. For more info do visit www.nuclearmedicinetherapy.in
0 notes
medcarediagnostics · 7 months
Text
Radionucleotide Therapy  In Mumbai – Medcare Daignostic
Exploring the Advancements of Radionuclide Therapy in Mumbai
Introduction
In recent years, the field of medical science has witnessed remarkable advancements, with innovative approaches to treating various diseases. One such groundbreaking development is Radionuclide Therapy, a targeted treatment method that utilizes radioactive substances to target and destroy cancerous cells while minimizing damage to healthy tissues. Mumbai, India's bustling metropolis, has emerged as a hub for cutting-edge medical treatments, including Radionuclide Therapy. In this blog, we will delve into the world of Radionuclide Therapy, its applications, benefits, and how Mumbai is at the forefront of providing this revolutionary treatment. Radionucleotide Therapy Specialist in Mumbai and be part of a transformative journey towards a healthier and brighter future.
Tumblr media
Understanding Radionuclide Therapy
Radionuclide Therapy, also known as targeted molecular therapy or molecular radiotherapy, involves the use of radioactive substances, known as radionuclides, to treat various medical conditions, primarily cancer. These radioactive substances emit radiation that damages the DNA within cancer cells, leading to their destruction. What sets Radionuclide Therapy apart is its precision; it specifically targets cancer cells while sparing healthy tissues, reducing the side effects commonly associated with traditional treatments like chemotherapy and radiation therapy.
Applications of Radionuclide Therapy
Cancer Treatment: Radionuclide Therapy is commonly used to treat certain types of cancer, such as thyroid cancer, neuroendocrine tumors, and bone metastases. The therapy can effectively target cancer cells that have spread to bones, offering relief from pain and improving the patient's quality of life.
Pain Management: In cases where cancer has metastasized to the bones, Radionuclide Therapy can provide significant pain relief by targeting the cancerous cells causing discomfort. This can greatly enhance the patient's overall well-being.
Hyperthyroidism Treatment: Radionuclide Therapy is employed to treat hyperthyroidism by administering a radioactive iodine isotope. This isotope selectively accumulates in the thyroid gland, helping to regulate its activity and treat the condition.
Peptide Receptor Radionuclide Therapy (PRRT): PRRT is an innovative approach used for treating neuroendocrine tumors. It involves attaching a radioactive substance to a peptide that binds to specific receptors on cancer cells, delivering radiation directly to the tumor.
Mumbai's Role in Advancing Radionuclide Therapy
Mumbai, a city renowned for its medical expertise and state-of-the-art facilities, has been a pioneer in the field of Radionuclide Therapy in India. The city boasts several leading healthcare institutions that offer advanced treatment options for cancer patients, including Radionuclide Therapy.
Cutting-edge Facilities: Mumbai is home to world-class medical facilities equipped with the latest technology for diagnosis, treatment, and research in the field of nuclear medicine and Radionuclide Therapy.
Expert Medical Professionals: The city attracts top-notch medical professionals, including nuclear medicine physicians, radiation oncologists, and radiologists, who are well-versed in the intricacies of Radionuclide Therapy.
Research and Innovation: Mumbai's healthcare institutions actively engage in research and innovation related to Radionuclide Therapy. Clinical trials and studies are conducted to continually enhance the effectiveness of this treatment approach.
Benefits of Radionuclide Therapy
Precise Targeting: Radionuclide Therapy's precision targeting ensures that cancer cells are destroyed while healthy tissues remain unharmed, minimizing side effects.
Reduced Pain and Discomfort: For patients with bone metastases or certain types of cancer, Radionuclide Therapy can alleviate pain and discomfort, significantly improving their quality of life.
Minimized Invasive Procedures: In some cases, Radionuclide Therapy can be administered through oral or intravenous methods, reducing the need for invasive surgeries.
Conclusion
Radionuclide Therapy has revolutionized the landscape of cancer treatment, offering a more targeted and effective approach while reducing the adverse effects commonly associated with conventional treatments. Mumbai's prominent role in advancing this field highlights the city's dedication to providing cutting-edge medical care to its residents and patients from around the world. With its state-of-the-art facilities, expert medical professionals Pathology Lab Near Me, Mumbai and commitment to research, Mumbai is poised to continue making significant contributions to the field of Radionuclide Therapy, providing hope and healing to countless individuals battling cancer and other medical conditions.
0 notes
Link
PRRT is a curative option for non-localised, heterogeneous, metastatic neuroendocrine tumours. PRRT has proven to be the most promising treatment modality amongst various systemic treatments such as Somatostatin Analogues, Chemotherapy, Molecular Targeted Treatments, Alpha Interferon etc. PRRT causes DNA damage to the tumour cells.
0 notes
amith9 · 4 years
Text
Paraganglioma Treatment Market is Booming Market to Grow at Healthy CAGR forecast by 2026
The Paraganglioma Treatment Market research report is a stunning aide for an imperative thought, improved fundamental authority and better business frameworks. The report joins estimations of the ongoing state of the market, CAGR values, market size and overall industry share, income age and significant changes required later on items. The Paraganglioma Treatment Market report has information and data as graphs, tables and outlines that can be adequately understood by the associations. The market thinks about, bits of learning and investigation joined into this overall Paraganglioma Treatment Market report keeps business focus indisputably into the concentration with which you can reach to the business objectives.
Market Analysis:
Global Paraganglioma Treatment Market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Presence of refined healthcare infrastructure and increase in special designation from the regulatory authorities are the key factors that drive the market
Influencing players of this market are:
Few of the major competitors currently working in the global paraganglioma treatment market are Progenics Pharmaceuticals, Inc, AstraZeneca, Advanced Accelerator Applications, Jubilant Life Sciences Ltd, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Cipla Inc, Amneal Pharmaceuticals LLC, Amerigen Pharmaceuticals Limited, Jiangsu Hengrui Medicine Co., Ltd, Fresenius Kabi AG, ONO PHARMACEUTICAL CO., LTD and others.
Get Exclusive Sample Copy of this Report@  
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-paraganglioma-treatment-market
This Paraganglioma Treatment Market report consolidates comprehensive industry examination with exact data and conjectures that offers total research arrangements and brings the most extreme industry clarity for decision making.
Analysis based on various segments-:
This analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimated forecast frame.
And this is done on the basis of-:
By Type
Sympathetic Paragangliomas
Parasympathetic Paragangliomas
By Site of Origin
Caroid Paragangliomas
Cervical Paragangliomas
Vagal Paragangliomas
Others
By Therapy Type
Radiation Therapy
Chemotherapy
Peptide Receptor Radionuclide Therapy (PRRT)
Others
By Treatment
Medication
Surgery
By Drugs
Iobenguane I 131
Cyclophosphamide
Vincristine
Dacarbazine
Others
By Route of Administration
Oral
Injectable
By End Users
Hospitals
Homecare
Specialty Clinics
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
S.
Canada
Mexico
Brazil
Rest of South America
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
South Africa
Rest of Middle East & Africa
Regional Insights-
Regional analysis helps the market players to take an exhaustive assessment of the Paraganglioma Treatment Market region wise so that it becomes easy for them to distinguish and investigate the developing pattern and hidden opportunities all over the world.
The Paraganglioma Treatment Market covers regions such as- South America, North America, Europe, Asia-Pacific, Middle East, and Africa.
Get Detailed TOC@
https://www.databridgemarketresearch.com/toc/?dbmr=global-paraganglioma-treatment-market
Analysis based on Competition-:
The Paraganglioma Treatment Market report presents profiles of key market players and information about different techniques they have utilized, for example, new product dispatches, extensions, understandings, joint endeavors, associations, acquisitions, and others to expand their impressions in this market so as to continue in long run.
Key queries addressed in this report-:
What will be the market size and market share in the upcoming future?
What are the new and hidden opportunities in the market?
Who are the top players in market?
How the challenge goes later on?
Which are the main regions impacting the market growth?
What are the difficulties in future?
Key Issues addressed here-:
Uncertainty of upcoming revenue pockets and growth areas.
Understanding business sector sentiments.
Understanding the most dependable venture focuses.
Competitiveness of Top industry players
Trending factors which are impacting the market growth.
Challenges and threats faced by the leading players
Research strategies and tools used-:
This Paraganglioma Treatment Market research report helps the readers to know about the overall market scenario, strategy to further decide on this market project. It utilizes SWOT analysis, Porter’s Five Forces Analysis and PEST analysis.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Report Related :
paresthesia  market
pharmaceutical equipment testing market
plexopathy treatment market
0 notes
Photo
Tumblr media
WORLD CANCER DAY
Some of the Best Cancer Hospitals in India offer cancer treatments like chemotherapy, radio therapy, IGRT, IMRT.
Many even offer more specialised treatment such as  PRRT, SBRT, Brachytherapy.
Preventive Diagnostics such as genetic testing for Breast Cancer, ( BRCA 1 , 2) play an important role in subsequent prevention.
Cost of Cancer Treatment varies from a US$ 5000-7000 to US$ 36000 if an allogenic bone marrow transplant is required for Leukemia.
To know more visit www.ihealthkonnect.com
0 notes
Photo
Tumblr media
Our Nuclear Oncology Experts have expertise in Alpha PSMA Therapy, I-131 MIBG Therapy, PRRT Therapy, I-131 For Thyroid Cancer, Actinium and Lutetium Therapy in India. For more info do visit www.nuclearmedicinetherapy.in
0 notes
Link
Our Nuclear Oncology Experts have expertise in Alpha PSMA Therapy, I-131 MIBG Therapy, PRRT Therapy, I-131 For Thyroid Cancer, Actinium and Lutetium Therapy in India. For more info do visit www.nuclearmedicinetherapy.in
1 note · View note
Text
lu 177 cancer treatment | NuclearMedicineTherapy
Discover the efficacy of Lu-177 in cancer treatment at NuclearMedicineTherapy. Explore the transformative potential and advancements in nuclear medicine, offering targeted solutions for various cancers.
Know more at:
0 notes
Text
PRRT is a molecular technique in which a radioisotope which is labeled with a small body that actually targets a particular receptor which is known as the somatostatin receptors is used to treat a specific kind of tumor known as a Neuroendocrine Tumor.
0 notes
Text
Neuroendocrine Tumors often present with large volume Liver Metastases and because these are relatively Indolent Tumors the patient often does not know that he has a Neuroendocrine Tumors specially those who have non-functioning Neuroendocrine Tumors.
0 notes
Text
Neuroendocrine Tumors often present with large volume Liver Metastases and because these are relatively Indolent Tumors the patient often does not know that he has a Neuroendocrine Tumors specially those who have non-functioning Neuroendocrine Tumors.
0 notes
Photo
Tumblr media
Several researches and clinical trials have shown that Peptide Receptor Radionuclide Therapy (PRRT) is an exciting and effective advancement in the treatment of Neuroendocrine Tumors (NETs).
  For more information on PRRT, do call us at +91 98111 27080,
  or write to us at [email protected] 
or visit https://nuclearmedicinetherapy.in/treatments/prrt
0 notes
Link
Best PRRT Therapy Centre for Neuroendocrine Tumours in India. To know more about what is PRRT, how it`s performed, benefits & its side-effects visit nuclearmedicinetherapy.in.
0 notes
Link
Find the best Actinium Ac225 Alpha PRRT Treatment for Neuroendocrine Tumors in India only at Nuclear Medicine Therapy. Targeted alpha PRRT has the potential to overcome many of the limitations of conventional Lu177 PRRT.
0 notes
Video
Neuroendocrine Tumors often present with large volume Liver Metastases and because these are relatively Indolent Tumors the patient often does not know that he has a Neuroendocrine Tumors specially those who have non-functioning Neuroendocrine Tumors.
0 notes
Link
0 notes